• Produktbild: The Kidney in Heart Failure
  • Produktbild: The Kidney in Heart Failure

The Kidney in Heart Failure

Fr. 150.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

08.08.2014

Herausgeber

George L. Bakris

Verlag

Springer Us

Seitenzahl

250

Maße (L/B/H)

23.5/15.5/1.5 cm

Gewicht

406 g

Auflage

2012

Sprache

Englisch

ISBN

978-1-4899-9811-8

Beschreibung

Rezension

From the reviews:

“This book discusses the epidemiology, pathophysiology, and medical management of kidney disease arising from heart failure. … designed to support the understanding and management of CKD in patients with heart failure, reviewing current practice in managing cardiorenal syndromes and concluding with advances in nephropathy management in patients … . Written by respected cardiologists and nephrologists, the book is intended for clinicians in both areas. … a well-written book that will prove useful in an academic healthcare setting or as continuing education for practice updates.” (Melissa K. Soper, Doody’s Review Service, January, 2013)

Portrait

Dr. Bakris is currently Professor of Medicine and Director of the Hypertension Center at the University of Chicago Pritzker School of Medicine. Dr. Bakris has published over 600 articles and book chapters in the areas of diabetic kidney disease, hypertension and progression of nephropathy. He is the Editor or Co-Editor of eight books, in the areas of Kidney Disease Progression and Diabetes. Additionally, he is the Associate Editor of the International Textbook of Cardiology. He chaired the first National Kidney Foundation Consensus report on blood pressure and impact on renal disease progression (2000). He has also served on many national guideline committees including: JNC VI and 7 writing committees, the JNC 7 executive committee, the American Diabetes Association Clinical Practice Guideline Committee. Dr. Bakris is also the past-president of the American College of Clinical Pharmacology and the current President of the American Society of Hypertension (ASH) (2010-2012). He is the current Editor of American Journal of Nephrology and Hypertension, Section Editor of Up-to-Date and Associate Editor of Diabetes Care and Nephrology, Dialysis & Transplant.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

08.08.2014

Herausgeber

George L. Bakris

Verlag

Springer Us

Seitenzahl

250

Maße (L/B/H)

23.5/15.5/1.5 cm

Gewicht

406 g

Auflage

2012

Sprache

Englisch

ISBN

978-1-4899-9811-8

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: The Kidney in Heart Failure
  • Produktbild: The Kidney in Heart Failure
  • Foreword                   Peter A. McCulloughPrefacePart One                     Epidemiology

    Chapter 1                    Epidemiology of Chronic Kidney Disease in Heart Failure

                                        Ruth C. Campbell and Ali Ahmed

    Chapter 2                    Anemia and Cardiovascular Risk in the Kidney Disease Patients:

                                        What is the best way to achieve and what is the desired hemoglobin?

                                        Tejas V. Patel and Ajay K. Singh

     Part Two                    PathophysiologyChapter 3                    Renal Hemodynamic Changes in Heart Failure

                                        Ivana Lazich and George L. Bakris

    Chapter 4                    Changes in Kidney Function Following Heart Failure Treatment:  Focus on RAS                                       Blockade

                                        Mohammed Shakaib and George L. Bakris

    Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                        Biff F. Palmer

    Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                        Ivan D. Hanson and Peter A. McCullough

     

    Part Three                 Management of Kidney Associated Clinical Problems

    Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                        Julian Segura and Luis M. Ruilope

    Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                        Andrew K. Roy and Patrick Murray

    Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                        Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

    Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                        Domenic A. Sica

    Chapter 11                  Ultrafiltration and Heart Failure

                                        Paul Chacko, Donald Kikta Jr., William T. Abraham

     

    Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

    Chapter 12                  Combination Therapy in Hypertension Treatment

                                        Raymond V. Oliva and George L. Bakris

    Chapter 13                  Medication Adherence in Heart Failure

                                        Daniel E. Hilleman and Jennifer A. Campbell

    Chapter 14                  New Markers of Vascular Risk

                                        David Davidson and Michael H. Davidson

    Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                        Raghu V. Durvasula and Katherine R. Tuttle

    PrefacePart One                     Epidemiology

    Chapter 1                    Epidemiology of Chronic Kidney Disease in Heart Failure

                                        Ruth C. Campbell and Ali Ahmed

    Chapter 2                    Anemia and Cardiovascular Risk in the Kidney Disease Patients:

                                        What is the best way to achieve and what is the desired hemoglobin?

                                        Tejas V. Patel and Ajay K. Singh

     Part Two                    PathophysiologyChapter 3                    Renal Hemodynamic Changes in Heart Failure

                                        Ivana Lazich and George L. Bakris

    Chapter 4                    Changes in Kidney Function Following Heart Failure Treatment:  Focus on RAS                                       Blockade

                                        Mohammed Shakaib and George L. Bakris

    Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                        Biff F. Palmer

    Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                        Ivan D. Hanson and Peter A. McCullough

     

    Part Three                 Management of Kidney Associated Clinical Problems

    Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                        Julian Segura and Luis M. Ruilope

    Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                        Andrew K. Roy and Patrick Murray

    Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                        Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

    Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                        Domenic A. Sica

    Chapter 11                  Ultrafiltration and Heart Failure

                                        Paul Chacko, Donald Kikta Jr., William T. Abraham

     

    Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

    Chapter 12                  Combination Therapy in Hypertension Treatment

                                        Raymond V. Oliva and George L. Bakris

    Chapter 13                  Medication Adherence in Heart Failure

                                        Daniel E. Hilleman and Jennifer A. Campbell

    Chapter 14                  New Markers of Vascular Risk

                                        David Davidson and Michael H. Davidson

    Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                        Raghu V. Durvasula and Katherine R. Tuttle

                                        Ivana Lazich and George L. Bakris

    Chapter 4                    Changes in Kidney Function Following Heart Failure Treatment:  Focus on RAS                                       Blockade

                                        Mohammed Shakaib and George L. Bakris

    Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                        Biff F. Palmer

    Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                        Ivan D. Hanson and Peter A. McCullough

     

    Part Three                 Management of Kidney Associated Clinical Problems

    Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                        Julian Segura and Luis M. Ruilope

    Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                        Andrew K. Roy and Patrick Murray

    Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                        Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

    Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                        Domenic A. Sica

    Chapter 11                  Ultrafiltration and Heart Failure

                                        Paul Chacko, Donald Kikta Jr., William T. Abraham

     

    Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

    Chapter 12                  Combination Therapy in Hypertension Treatment

                                        Raymond V. Oliva and George L. Bakris

    Chapter 13                  Medication Adherence in Heart Failure

                                        Daniel E. Hilleman and Jennifer A. Campbell

    Chapter 14                  New Markers of Vascular Risk

                                        David Davidson and Michael H. Davidson

    Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                        Raghu V. Durvasula and Katherine R. Tuttle

                                        Mohammed Shakaib and George L. Bakris

    Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                        Biff F. Palmer

    Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                        Ivan D. Hanson and Peter A. McCullough

     

    Part Three                 Management of Kidney Associated Clinical Problems

    Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                        Julian Segura and Luis M. Ruilope

    Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                        Andrew K. Roy and Patrick Murray

    Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                        Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

    Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                        Domenic A. Sica

    Chapter 11                  Ultrafiltration and Heart Failure

                                        Paul Chacko, Donald Kikta Jr., William T. Abraham

     

    Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

    Chapter 12                  Combination Therapy in Hypertension Treatment

                                        Raymond V. Oliva and George L. Bakris

    Chapter 13                  Medication Adherence in Heart Failure

                                        Daniel E. Hilleman and Jennifer A. Campbell

    Chapter 14                  New Markers of Vascular Risk

                                        David Davidson and Michael H. Davidson

    Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                        Raghu V. Durvasula and Katherine R. Tuttle